News from CEXS
New technologies are increasingly important in drug discovery, especially today, when both the cost of biomedical research and the number of compound failures are on the rise. New tools combining nanotechnologies and life sciences enable progress on the development of new drugs and disease modelling. Biomedical research needs these novel tools to continue to advance at a pace that justifies the cost.
This will be the main topic of discussion at the conference 'Future tools for biomedical research: In vitro, in silico and in vivo disease modelling', scheduled to take place on 1 and 2 October at CosmoCaixa Barcelona. The event is being jointly organized by B·Debate and the Institute for Bioengineering of Catalonia (IBEC). Ricard Solé, head of the Complex Systems Lab in the UPF Department of Experimental and Health Sciences (DCEXS), will give a talk the first day entitled ' Systems biology approaches to cell biology'.
The scientific committee is made up of Josep Samitier, director of IBEC, Roger Guimerà, ICREA Research Professor in the Department of Chemical Engineering at Rovira i Virgili University (URV), Fàtima Bosch, director of the Centre of Animal Biotechnology and Gene Therapy (CBATEG) at the Autonomous University of Barcelona (UAB), Àngel Raya, ICREA Research Professor and director of the Center of Regenerative Medicine in Barcelona (CMR[B]), Miquel Borràs, associate professor of toxicology in the Department of Pharmacology and Therapeutic Chemistry at the University of Barcelona (UB), and Xavier Trepat, ICREA Research Professor and Group Leader of the Integrative Cell and Tissue Dynamics research line at the IBEC.
The conferences organized as part of the B-Debate programme are high-level international scientific meetings in which renowned experts discuss current topics in panels moderated by leading scientists.